Re-treatment rate was 2.2% in Group 1 and 8.2% in Group 2, which is highly significant ( p < 0.01).
also in 132,142 other papers
Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.